Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 14 min ago
Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer

183 An accelerated, scalable manufacturing platform generates highly purified and functionally superior CAR T cell products for chronic lymphocytic leukemia

  • David Wald1
  • Paolo Caimi2
  • Xiaojian Han3
  • Beatriz Coutinho de Oliveira4
  • Cassandra K Gilmour5
  • Emma Arra4
  • Malaak Jawhari4
  • Saaurav Bari4
  • Jessica Kerr4
  • Jan Joseph Melenhorst5
  • Celine Gregoire6
  • Arun K Arunachalam7
1 more authors
  • Lora Topalof4
7 affiliations
  1. 1Case Western Reserve University, Cleveland, OH, USA
  2. 21Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA
  3. 3Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing, China
  4. 4Cleveland Clinic, Cleveland, OH, USA
  5. 5Department of Cancer Sciences, Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic Research, Cleveland Clinic, Cleveland, OH, USA
  6. 6Centre Hospitalier Universitaire de Liège, Liège, Belgium
  7. 7Christian Medical College, Vellore, India
Open at sourcePDFDOICite

Related

  1. Diagnosis of NK–large granular lymphocytic leukemia
    Cédric Pastoret, Thierry Lamy, Mikaël Roussel
    Blood AdvancesPeer-reviewedCC BY-NC-ND 4.0Full textGeneral biologyOncologyHAL
  2. Richter Transformation of Chronic Lymphocytic Leukaemia: Biology, Diagnosis, and an Evolving Therapeutic Landscape
    Juan Marquet-Palomanes, Fernando Martin-Moro, Jose A. Garcia-Vela
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. A Rare Case of Chronic Lymphocytic Leukemia and Chronic Myeloid Leukemia in an Elderly Patient: A Case Report
    Mostafa Kamandi, Mohammad Mahdi Alvandi Fard
    Clinical case reportsPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Aplastic Anaemia in a Chronic Lymphocytic Leukaemia Patient Treated With Acalabrutinib, a Bruton Tyrosine Kinase Inhibitor—Case Report
    Zachray Wei, Tamara Marconi, Lucy Tuck +1
    EJHaemPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  5. Current Evidence, Diagnostic Challenges, and Contemporary Management of Lymphocytic Colitis: A Case Report and Literature Review
    Oziegbe Egbo, Ojevwe H Egbo, Faith I Omoregie +1
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@article{wald2026accelerated,
  title = {{183 An accelerated, scalable manufacturing platform generates highly purified and functionally superior CAR T cell products for chronic lymphocytic leukemia}},
  author = {David Wald and Paolo Caimi and Xiaojian Han and Beatriz Coutinho de Oliveira and Cassandra K Gilmour and Emma Arra and Malaak Jawhari and Saaurav Bari and Jessica Kerr and Jan Joseph Melenhorst and Celine Gregoire and Arun K Arunachalam and Lora Topalof},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2026},
  month = nov,
  doi = {10.1136/jitc-2026-sitc2026.0183},
  url = {https://doi.org/10.1136/jitc-2026-sitc2026.0183},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - 183 An accelerated, scalable manufacturing platform generates highly purified and functionally superior CAR T cell products for chronic lymphocytic leukemia
AU  - David Wald
AU  - Paolo Caimi
AU  - Xiaojian Han
AU  - Beatriz Coutinho de Oliveira
AU  - Cassandra K Gilmour
AU  - Emma Arra
AU  - Malaak Jawhari
AU  - Saaurav Bari
AU  - Jessica Kerr
AU  - Jan Joseph Melenhorst
AU  - Celine Gregoire
AU  - Arun K Arunachalam
AU  - Lora Topalof
PY  - 2026
DA  - 2026/11/07
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1136/jitc-2026-sitc2026.0183
UR  - https://doi.org/10.1136/jitc-2026-sitc2026.0183
SN  - 2051-1426
ER  -